WHO ICTRP trial
A study investigating the effect of different approved medications on how the…
CTIS2024-517360-37-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-517360-37-00 |
|---|---|
| Public title | A study investigating the effect of different approved medications on how the body processes the study compound RO7795081. RO7795081 is a new compound that may potentially be used in the treatment of type 2 diabetes and weight control. |
| Scientific title | - BP45670 |
| Primary sponsor | F. Hoffmann-La Roche AG |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Netherlands |
| Conditions | Type 2 Diabetes and obesity MedDRA version: 21.1Level: LLTClassification code: 10045260Term: Type II obese diabetic Class: 10027433;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18] |
| Registration date | Sep 23, 2024 |
| Target size | 50 |
| Registry page | euclinicaltrials.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: